JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by PFEIFFER, C. C.
Right arrow Articles by TATUM, A. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by PFEIFFER, C. C.
Right arrow Articles by TATUM, A. L.
Journal of Pharmacology And Experimental Therapeutics, Vol. 53, Issue 3, 358-376, 1935
Copyright © 1935 by American Society for Pharmacology and Experimental Therapeutics


A NEW EXPERIMENTAL APPROACH TO THE STUDY OF THE RÔLE OF THE RETICULO-ENDOTHELIAL SYSTEM IN THE CURE OF TRYPANOSOMIASIS

CARL C. PFEIFFER 1 and ARTHUR L. TATUM 1

1 From the Department of Pharmacology of the University of Wisconsin, Madison, Wisconsin

If trypanosomes are treated in vivo for five minutes with 5 mgm. per kilogram mapharsen and the rat's blood then placed in a test tube, the trypanosomes do not die or disappear in fifteen minutes as they do in vivo, but continue to live on for eighty minutes.

The same is true if the rat is killed five minutes after treatment, when the trypanosomes instead of disappearing from the dead host in fifteen minutes may be found and are still infective for an average of seventy-five minutes.

Transplants of the organs of a treated rat taken at the time of disappearance of the trypanosomes from the blood stream indicate a greater accumulation of trypanosomes in the liver than in any other organ.

Acute experiments in which the liver, spleen and kidneys are ligated support the above data in that the ligation of the liver is the only procedure which materially lengthens the disappearance time. The undoubted rôle played by the spleen under other experimental conditions appears to be eclipsed by the activity of the liver under the conditions described in this report.

Since the drug has no effect on "arsenic resistant" trypanosomes in vivo, the logical conclusion is that mapharsen intoxicates the normal trypanosomes which are then removed from the circulating blood and subsequently destroyed through the activity of the reticulo-endothelial system.

Submitted on January 21, 1935







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1935 by the American Society for Pharmacology and Experimental Therapeutics.